New Cloud-Based Investigator Portal From Veeva Systems Speeds Clinical Study Start-Up
Also announced at DIA 2013 today, Veeva adds critical publishing capabilities to Vault Submissions - the industry's first cloud-based application for managing submissions content. Visit the company's booth # 1557 for demonstrations of the new Vault Investigator Portal as well as Vault Submissions.
About Veeva Vault Development Suite
Vault Investigator Portal is part of the Veeva Development Suite, the only cloud-based suite of integrated content management applications for the life sciences industry. Spanning every major part of a life sciences company - from R&D to clinical trials, to quality and manufacturing - the Veeva Development Suite gives pharmaceutical, biotechnology and medical device companies the ability to deploy a single content management system globally. All Development Suite applications offer real-time reporting and dashboards, an intuitive web interface, and a true multitenant cloud architecture that continuously delivers rapid innovation.
About Veeva Systems Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 150 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Budapest, London, Paris, Beijing, Shanghai and Tokyo. For more information, visit http://www.veeva.com.Copyright (c) 2013 Veeva Systems. All rights reserved. Veeva and the Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners. Media Contact Lisa Barbadora Veeva Systems, Inc. email@example.com SOURCE Veeva Systems
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts